A central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trial
E Provenzano, A-L Vallier, R Champ, K Walland, S Bowden, A Grier, N Fenwick, J Abraham, M Iddawela, C Caldas, L Hiller, J Dunn, HM Earl
British Journal of Cancer | NATURE PUBLISHING GROUP | Published : 2013
Awarded by Cancer Research UK
We thank all participating clinicians, histopathologists, research nurses and patients. Data Monitoring Committee members are Professor Lucca Gianni, Professor Craig Henderson and Professor Mark Brady. Research support was obtained from Cancer Research UK: Project grant for Neo-tAnGo clinical trial - C57/A4180 2004-9 (HME); Eli Lilly and Company - unrestricted partnership educational grant for additional trial co-ordination support and free gemcitabine (HME); Bristol Myers Squibb - discounted Taxol. HME, and EP receive support from the Cambridge Experimental Cancer Medicine Centre and the NIHR Cambridge Biomedical Research Centre.